Mckinley Capital Management LLC Repligen Corp Transaction History

Mckinley Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $3.36 Million - $4.14 Million	13,590 New	13,590 $3.6 Million
Q2 2019 Aug 07, 2019	SELL	$54.2 - $85.95 $29,864 - $47,358	-551 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$48.26 - $68.88 $29,100 - $41,534	-603 Reduced 52.25%	551 $29,000
Q3 2018 Nov 08, 2018	SELL	$46.8 - $58.97 $4,399 - $5,543	-94 Reduced 7.53%	1,154 $64,000
Q2 2018 Jul 13, 2018	SELL	$35.26 - $47.04 $4,019 - $5,362	-114 Reduced 8.37%	1,248 $59,000
Q1 2018 May 04, 2018	SELL	$30.92 - $37.27 $1.16 Million - $1.39 Million	-37,400 Reduced 96.49%	1,362 $49,000
Q4 2017 Feb 08, 2018	BUY	$32.53 - $38.92 $650 - $778	20 Added 0.05%	38,762 $1.41 Million
Q3 2017 Nov 13, 2017	BUY	$36.98 - $46.06 $22,151 - $27,589	599 Added 1.57%	38,742 $1.49 Million
Q2 2017 Aug 14, 2017	BUY	N/A	38,143	38,143 $1.58 Million

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.94B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Mckinley Capital Management LLC , based on Form 13F filings with the SEC.

Stay updated on Mckinley Capital Management LLC with notifications on news.